LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes.

[1]  N. Paquot,et al.  How to measure insulin action in vivo. , 1994, Diabetes/metabolism reviews.

[2]  C. Packard,et al.  Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  R. Krauss,et al.  LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women , 1993, Circulation.

[4]  K. Alberti,et al.  Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  R. Krauss,et al.  Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. , 1993, The Journal of clinical investigation.

[6]  R. Krauss,et al.  Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[8]  M. Taskinen,et al.  Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes , 1993, Diabetes Care.

[9]  W. Sheu,et al.  Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  J. Hokanson,et al.  Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[12]  E. Blijlevens,et al.  LDL particle size distribution. Results from the Framingham Offspring Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  R. Krauss,et al.  LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  G. Paolisso,et al.  Hyperinsulinemia in patients with hypercholesterolemia. , 1992, The Journal of clinical endocrinology and metabolism.

[15]  P. Wilson,et al.  Change in LDL particle size is associated with change in plasma triglyceride concentration. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  S. Haffner,et al.  Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) , 1992, Diabetes.

[17]  M. Taskinen,et al.  Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. , 1992, Journal of lipid research.

[18]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Willett,et al.  Nutrient intake comparisons between Framingham and rural and Urban Puriscal, Costa Rica. Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  J. Ordovás,et al.  Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[22]  P. Gambert,et al.  Human low density lipoprotein subfractions separated by gradient gel electrophoresis: composition, distribution, and alterations induced by cholesteryl ester transfer protein. , 1990, Journal of lipid research.

[23]  U. Smith,et al.  Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease , 1990, Journal of internal medicine.

[24]  M. Laakso,et al.  Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. , 1990, Arteriosclerosis.

[25]  M. King,et al.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1988, American journal of human genetics.

[26]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[27]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[28]  P. Raskin,et al.  Relationship between lipoprotein levels and in vivo insulin action in normal young white men. , 1988, Metabolism: clinical and experimental.

[29]  M. Taskinen,et al.  Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia , 1988, Diabetes.

[30]  H. Halkin,et al.  Hyperinsulinemia Is Characterized by Jointly Disturbed Plasma VLDL, LDL, and HDL Levels: A Population‐Based Study , 1988, Arteriosclerosis.

[31]  D. Kritchevsky.  Drugs Affecting Lipid Metabolism , 1988, Proceedings in Life Sciences.

[32]  P. Wilson,et al.  Effect of Gender, Age, and Lipid Status on Low Density Lipoprotein Su bf raction Distribution: Results from the Framingham Offspring Study , 1987, Arteriosclerosis.

[33]  S. Lillioja,et al.  Relationships Between Plasma Lipoprotein Concentrations and Insulin Action in an Obese Hyperinsulinemic Population , 1987, Diabetes.

[34]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[35]  G. Reaven,et al.  Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. , 1981, Metabolism: clinical and experimental.

[36]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[37]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[38]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[39]  H. Yki-Järvinen,et al.  Hyperuricemia and insulin resistance. , 1994, The Journal of clinical endocrinology and metabolism.

[40]  M. Laakso,et al.  Insulin resistance in familial and nonfamilial hypercholesterolemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[41]  M. Taskinen.  FACTORS INFLUENCING THE ALTERED LIPOPROTEIN SYSTEM IN HYPERTRIGLYCERIDEMIA , 1993 .

[42]  R. Krauss,et al.  Linkage analysis of low‐density lipoprotein subclass phenotypes and the apolipoprotein B gene , 1991, Genetic epidemiology.

[43]  J. Ordovás,et al.  Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size, and apolipoproteins. , 1989, The Journal of clinical endocrinology and metabolism.